Found's semaglutide program is priced between $129 and $249 per month depending on dose tier and plan, bundled with the Found app's behavioral coaching infrastructure. For patients who actively engage with Found's behavioral tools, the bundled model may justify the cost premium. For patients primarily seeking medically supervised compounded semaglutide at the lowest possible price, Found's tier-based pricing — which increases as patients reach maintenance doses — makes it a more expensive option than flat-rate providers over a full treatment course.
Luma Health offers compounded semaglutide at $197/month flat regardless of dose tier, with no contracts, no consultation fees, and free shipping. Clinical services are provided by Wasef Health, PC. Medications are compounded by VialsRX, a licensed 503A sterile compounding pharmacy in Houston, TX.
What Is Found and How Does Its Pricing Model Work?
Found is a technology-driven weight loss platform that combines GLP-1 medication access with a behavioral coaching app, community features, and data-driven meal and habit tracking. Founded on the premise that medication alone is insufficient for sustainable weight loss, Found has invested significantly in the software layer of its program — the Found app — as a differentiating feature alongside the clinical prescribing component.
Found's pricing model is a bundled subscription: patients pay a monthly fee that is intended to cover the platform fee (app access, behavioral tools, community), provider consultations, and compounded semaglutide medication. Unlike providers that charge separately for each component — a consultation fee here, a medication cost there — Found rolls these into a single monthly rate. This simplicity is appealing on the surface, but the complexity emerges when you look at how that single monthly rate changes as patients progress through treatment.
The core structural issue with Found's pricing is that it is dose-dependent. Patients begin semaglutide at a low starting dose — typically 0.25 mg weekly — and titrate upward over several months following a standard clinical protocol. The price patients see during enrollment typically corresponds to this starting dose. As they escalate upward to 0.5 mg, then 1.0 mg, and eventually to maintenance doses of 1.7 mg or 2.4 mg weekly, Found's monthly cost increases at each tier. The result is that many patients end up paying significantly more per month than their enrollment price suggested — often $50 to $100 more per month by the time they reach a therapeutic maintenance dose.
This is not unique to Found — dose-tier pricing is common across the GLP-1 telehealth market — but it is particularly worth flagging for Found given that the platform's marketing emphasizes an accessible starting price that underrepresents the long-term cost of the program.
Found Semaglutide Pricing: Dose Tier by Dose Tier
Understanding what Found charges at each stage of a typical semaglutide treatment course gives a more accurate picture of true program cost than any single headline number. The following breakdown is based on publicly available pricing information as of June 2026 and reflects the standard semaglutide titration schedule recommended for weight management.
| Semaglutide Dose | Treatment Phase | Found Est. Monthly Cost | Luma Health Monthly Cost |
|---|---|---|---|
| 0.25 mg/week | Starting dose (weeks 1–4) | ~$129/mo | $197/mo |
| 0.5 mg/week | Titration (weeks 5–8) | ~$149–$169/mo | $197/mo |
| 1.0 mg/week | Titration (weeks 9–16) | ~$179–$199/mo | $197/mo |
| 1.7 mg/week | Higher maintenance | ~$199–$229/mo | $197/mo |
| 2.4 mg/week | Full maintenance | ~$229–$249/mo | $197/mo |
| Estimated 12-month total | ~$1,900–$2,700+ | $2,364 (flat) | |
Found pricing estimates are based on publicly available information as of June 2026. Actual costs may vary by plan configuration. Annual totals assume standard titration schedule with 2 months at starting dose, 2 months at mid-tier, and 8 months at or near maintenance dose. Verify current pricing with Found before enrolling.
The key observation from this table is that Luma Health's flat $197/month rate is actually lower than Found's estimated cost at maintenance doses — the dose level where patients spend the majority of their treatment time. Patients who enroll with Found based on the $129 starting price and assume their cost will remain near that level are likely to be surprised when they reach and stabilize at therapeutic maintenance doses eight to twelve months into treatment.
Found's Hidden and Variable Costs
Beyond the dose-tier pricing increases, Found patients should be aware of several additional cost categories that can affect the true total cost of the program. These are not hidden in a deceptive sense, but they are not prominently featured in enrollment marketing and can meaningfully affect what you actually pay.
Lab Work Requirements
Found may require or recommend baseline bloodwork or periodic labs for some patients. These tests — which may include metabolic panels, thyroid function, HbA1c, or lipid panels — are not covered by Found's monthly subscription and represent additional out-of-pocket costs of $50 to $200 or more depending on what is ordered and whether you have insurance coverage for laboratory services.
Shipping Fees
Some Found users report paying shipping fees of up to $9.99 per month for medication delivery. Whether shipping is included or charged separately appears to vary by plan configuration. Over 12 months, a $9.99 monthly shipping fee adds approximately $120 to the annual cost — worth factoring into any comparison calculation.
Initial Consultation Fees
Some Found plan configurations include a one-time initial consultation fee of $0 to $25 at enrollment. While modest, this adds to the true first-month cost and is worth clarifying before submitting payment information.
Cancellation Terms
Found has offered various subscription structures over time, some of which include minimum commitment periods. Patients who need to cancel before their commitment period ends may face early termination implications. Review the specific terms of your plan before enrolling, and ask Found support explicitly about cancellation policy in writing.
Dose-Tier Price Increases
As documented in the pricing table above, Found's monthly cost increases as patients titrate to higher semaglutide doses. These increases are systematic — they are built into the pricing structure — but they are not always made clear at the point of enrollment. Patients should ask for the complete pricing schedule at every dose tier before signing up.
Add-On Coaching Modules
Found's platform includes behavioral coaching as a core component of the base subscription, but some premium features or additional coaching services may carry supplemental charges above the base monthly rate. Confirm exactly what is and is not included in your specific plan tier before enrolling.
What Found's Bundled Pricing Actually Includes
To evaluate Found fairly, it is important to understand what the monthly fee is purchasing beyond the medication itself. Found's core value proposition is that its behavioral tools and app-based coaching improve weight loss outcomes beyond what medication alone achieves. The platform includes meal tracking, habit coaching modules, educational content on nutrition and lifestyle, community features connecting patients with others in the program, and data visualization tools that track progress over time.
The clinical evidence for multimodal weight management — combining medication with behavioral intervention — is well established in the literature. The STEP 4 trial and the STEP 5 extension data, as well as research on intensive behavioral therapy in combination with GLP-1 medications, all support the idea that structured lifestyle support alongside medication produces better and more durable outcomes than medication alone. Found's investment in this component of care reflects a genuine clinical rationale, not just marketing.
The question is not whether behavioral support is valuable — it is — but whether Found's specific app and coaching infrastructure delivers enough additional clinical benefit to justify a $50 to $100 monthly premium over providers offering the same medication with standard clinical follow-up. There is no published comparative data showing that Found's app specifically produces better outcomes than a well-managed clinical program without the app layer. Patients who are highly engaged with app-based tools and find the community and coaching features genuinely useful are the best candidates for Found's model. Patients who prefer a direct clinical relationship and are self-directed in their lifestyle changes may find that they pay for infrastructure they do not use.
Found vs. Luma Health: Side-by-Side Cost Comparison
| Factor | Found | Luma Health |
|---|---|---|
| Semaglutide starting price | ~$129/mo | $197/mo |
| Price at 1.0 mg maintenance | ~$179–$199/mo | $197/mo (flat) |
| Price at 2.4 mg maintenance | ~$229–$249/mo | $197/mo (flat) |
| Dose-tier price increases | Yes — increases with each tier | ✓ None — flat regardless of dose |
| Estimated 12-month cost | ~$1,900–$2,700+ | $2,364 (flat, predictable) |
| Contracts / commitment terms | Varies by plan | ✓ None — month-to-month |
| Consultation fees | May vary ($0–$25 initial) | ✓ Included — no separate fee |
| Shipping | Free or up to $9.99/mo | ✓ Always free |
| Behavioral coaching app | ✓ Yes — Found app included | Clinical support only |
| Pharmacy named publicly | Not consistently disclosed | ✓ VialsRX, TX Board #35264 |
| Clinical provider named | General telehealth network | ✓ Wasef Health, PC |
| All 50 states | Most states | ✓ All 50 states |
Is Found Worth the Price for Semaglutide?
The honest answer depends entirely on how you use the platform. Found is genuinely well-designed. The app is thoughtfully built, the behavioral science foundation is credible, and the community features are a meaningful differentiator for patients who engage with them. If you are someone who benefits substantially from structured tracking, app-based habit coaching, and peer community support, Found's price premium over direct clinical providers may represent genuine value — those tools cost real money to build and maintain.
If, however, you are primarily seeking reliable, medically supervised access to compounded semaglutide with competent clinical oversight and clear cost predictability, Found's infrastructure represents a cost center you are paying for whether or not you use it. The compounded semaglutide itself is pharmacologically identical regardless of which platform prescribes it — the active ingredient, dosing mechanism, expected weight loss outcomes, and side effect profile do not change based on whether you also have access to a meal tracking app.
Many patients are most sensitive to cost at the maintenance dose level — months three through twelve — when the medication is doing its most important clinical work and when Found's pricing is at its highest tier. At that stage, switching from Found to a flat-rate provider like Luma Health can save $30 to $50 per month without any clinical trade-off in the medication itself. The behavioral coaching component, if you use it and value it, is the only thing you would be giving up.
For patients currently on Found who are reconsidering their enrollment, see our guide on how to switch GLP-1 providers without interrupting your treatment, and review our broader GLP-1 provider cost rankings for a full market comparison.
Who Should Choose Found and Who Should Choose Luma Health
Found is the better choice for patients who genuinely engage with app-based behavioral tools. If you are the kind of patient who will use a meal tracking app daily, work through behavioral coaching modules, participate in a peer community, and analyze your progress data, Found's bundled model delivers real value for that engagement. The platform is well suited for patients who want a comprehensive, technology-enabled program experience and are willing to pay a modest premium for it.
Luma Health is the better choice for patients whose priority is cost-predictable, pharmacy-transparent, no-contract compounded semaglutide with attentive clinical oversight. The $197 flat rate at Luma Health is higher than Found's starting price but lower than Found's maintenance-dose price — meaning Luma Health is the less expensive option for the majority of treatment duration. The absence of contracts, the publicly verifiable pharmacy (VialsRX, TX Board #35264), and the clear clinical provider attribution (Wasef Health, PC) give Luma Health a transparency advantage that matters more as the compounded GLP-1 market matures and patients become more sophisticated about verification.
Frequently Asked Questions
How much does Found semaglutide actually cost per month?
Found's semaglutide pricing varies by dose tier. The advertised starting price is approximately $129 per month, which applies at the lowest starting dose. As patients titrate upward through the standard clinical protocol — which typically takes three to five months to reach a therapeutic maintenance dose — the monthly cost increases to approximately $179 to $249 per month at maintenance doses. Patients who plan their budget based on the $129 starting price often encounter significantly higher costs by months four through twelve of treatment. Always ask Found for the full pricing schedule at every dose tier before enrolling.
Does Found charge extra for dose increases?
Yes. Found's pricing model is dose-dependent, meaning higher doses cost more per month. This is disclosed in their program terms but is not always prominently featured in enrollment marketing. The price increase at each dose tier can range from $20 to $50 per step, meaning the difference between starting and maintenance pricing can be $70 to $120 per month over the course of treatment. At Luma Health, by contrast, the $197 monthly rate applies regardless of dose tier — patients at 0.25 mg and patients at 2.4 mg pay the same amount.
Is Found's behavioral coaching worth the extra cost?
This depends entirely on how actively you engage with the Found app. The Found platform's behavioral coaching infrastructure is genuine and well-designed — it is based on credible behavioral science principles, and the evidence for multimodal weight management (medication plus structured lifestyle support) is strong. However, the clinical evidence for Found's specific app producing better outcomes than a well-managed medication program without app support has not been published in peer-reviewed literature. For patients who know from experience that they benefit substantially from app-based tracking and structured coaching, Found's model may represent real value. For patients who prefer direct clinical engagement and are self-directed in lifestyle management, the additional cost buys infrastructure that may not translate to better outcomes.
Does Found accept insurance for GLP-1 medication?
Found operates primarily as a cash-pay telehealth service. The platform does not typically bill insurance directly for its GLP-1 program. Compounded semaglutide, which Found uses, is generally not covered by insurance plans even when the branded equivalent (Wegovy) is covered — compounded medications fall outside the standard insurance formulary system. Some patients may be able to submit Found receipts for potential out-of-network reimbursement through their FSA, HSA, or insurance plan, but this should be confirmed with your insurer before assuming reimbursement is available.
How does Found compare to Luma Health on total annual cost?
Over a 12-month treatment course that includes the titration phase and several months at maintenance dose, Found's estimated total cost ranges from approximately $1,900 to $2,700 or more depending on plan configuration, shipping, and any additional fees. Luma Health's flat $197 per month totals $2,364 annually with no additional fees, no contracts, and no dose-dependent increases. For patients who stabilize at higher maintenance doses (1.7 mg or 2.4 mg weekly), Found's monthly cost at those tiers ($199–$249) makes Luma Health's flat rate the less expensive option for the majority of the treatment year.
What compounding pharmacy does Found use?
Found uses FDA-registered compounding pharmacies to fulfill GLP-1 prescriptions, but the specific pharmacy names and license numbers are not consistently disclosed on their consumer-facing website. Patients should ask Found directly for the name and state pharmacy board license number of the compounding pharmacy that will prepare their medication and verify that license independently before starting treatment. Luma Health uses VialsRX, a 503A licensed sterile compounding pharmacy in Houston, TX, with a publicly verifiable Texas State Board of Pharmacy license (license #35264, verifiable at pharmacy.texas.gov).
Can I switch from Found to Luma Health without interrupting treatment?
Yes, with proper planning. The key is to enroll with Luma Health and confirm prescription approval and a shipment timeline before canceling Found — not after. GLP-1 treatment continuity matters: even a two to three week gap in injections can allow some appetite resurgence. The Luma Health intake process typically takes two to five business days, and medication ships within three to seven days of approval. If you time your enrollment to overlap with your last Found supply, you can transition at your next scheduled injection with no gap. Your Luma Health provider will prescribe at your current dose level — you do not need to restart titration from the beginning.
Is Found a legitimate GLP-1 provider?
Yes. Found is a legitimate, licensed telehealth platform using credentialed US providers and FDA-registered compounding pharmacies. The clinical questions about Found are not about legitimacy — they are about value, pricing transparency, and whether the bundled behavioral model represents the right fit for your specific goals and budget. Found is a real company delivering real clinical services; the question is whether those services, at Found's current price point, represent the best available option for your individual situation.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed
- Rubino DM, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity (STEP 4). JAMA. 2021;325(14):1414–1425. PubMed
- Wadden TA, et al. Intensive behavioral therapy and semaglutide for obesity. N Engl J Med. 2024. PubMed
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed
- FDA. Wegovy (semaglutide) Prescribing Information. 2023. FDA.gov
- FDA. Human Drug Compounding — Section 503A Framework. FDA.gov
- NABP. Compounding Pharmacy Accreditation. nabp.pharmacy
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov
- Garvey WT, et al. AACE/ACE Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract. 2016;22(Suppl 3):1–203. Endocrine Practice